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Introduction
Sex hormones including progesterone, androgens, and
estrogen produced de novo from cholesterol within the
ovary play important roles in the growth and dif-
ferentiation of reproductive tissues and in the main-
tenance of fertility [1]. The precise role of sex hormones
in follicular development remains to be elucidated.
Ovarian follicular development relies on the interaction
between the pituitary gonadotropins follicle stimula-
ting hormone (FSH) and luteinizing hormone (LH) (and
glucocorticoid hormone and prolactin in some species)
and intraovarian factors, such as steroids, cytokines,
and other growth factors. Some effects of FSH, such as
stimulation of steroidogenesis, are enhanced by an-
drogens and/or estrogens. Androgens produced by
LH-stimulated thecal cells are of central importance
in the ovarian paracrine system since they directly
augment granulosa cell responsiveness to FSH and
serve as obligatory substrates for estrogen synthesis in
preovulatory follicles. Androgens act as substrates for
estrogen synthesis under the classical two-cell, two-
gonadotropin model [2,3]. Ample evidence exists to
indicate that thecal cells possess the full complement of
steroidogenic enzymes necessary for estrogen synthesis.
In contrast, estrogen synthesis by granulosa cells is
dependent on thecal-derived androgens as substrates
for aromatization. The amount and activity of expressed
steroidogenic enzymes within the two cell types vary
depending on the follicular stage, thereby determining
the predominant steroid produced. The cell-specific
and temporal actions of the gonadotropins LH and FSH
regulate the type and activity of steroidogenic enzymes
expressed within the granulosa and thecal cells. The
model states that LH acting via the constitutively
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expressed LH receptor on the cell surface of thecal cells
stimulates the synthesis of androgens (androstenedione)
in the growing follicle. This requires the initial conver-
sion of the cholesterol side-chain cleavage enzyme
(P450scc) and is thought to be a rate-limiting step in
thecal-cell steroidogenesis. Still within the thecal cells,
pregnenolone is converted to progesterone and then to
androstenedione via the enzymatic actions of 3`-
hydroxysteroid dehydrogenase and 17_-hydroxylase/
C17–20 lysate (P45017_), respectively. Regulation by LH
occurs at both the transcriptional and translational
levels for the P450scc and P45017_ genes. Granulosa cells
lack expression of the P45017_ enzymes required to
produce androgens, the precursor of estrogen, and are
therefore dependent on the passage of thecal-derived
androgens through the basement membrane and into
the granulosa compartment. This cellular cooperation
provides the basis of the two-cell portion of the model.
The second gonadotropin, FSH, acts solely on the
granulosa cells to stimulate the enzymatic conversion of
androstenedione and testosterone to estrone and
estradiol, via P450-aromatase (P450arom) and 17`-
hydroxysteroid dehydrogenase, respectively. The
estradiol is then released into the follicular fluid, from
where the bulk passes back through the basement
membrane and enters the circulation. On ovulation, the
luteal phase begins with luteinization of the follicle and
differentiation of the remaining granulosa and thecal
cells to form the corpus luteum. The relative amounts
and activities of the steroidogenic enzymes are altered
once again and shift toward synthesis of large amounts
of progesterone. Sex hormone effects are often mediated
through the sex hormone receptors [4]. Sex hormone
receptors, members of the steroid receptor superfamily,
function as sex hormone-dependent transcriptional
regulators, and all contain common structural elements
[5]. These include a highly conserved DNA binding
domain (DBD), a moderately conserved ligand binding
domain (LBD) and two transactivation domains, AF1
located in domain A/B and AF2 in domain E/F [6].
Binding of steroid hormones to the specific sex
hormone receptor LBD induces a conformational
modification of the receptor, followed by the separation
of the receptor from cytoplasmic chaperone proteins
such as heat-shock protein 90 (Hsp90) and by the
exposure of nuclear localization sequences. This allows
nuclear translocation and homo/heterodimerization of
the ligand-bound receptors, and their binding to
palindromic DNA sequences, called sex hormone re-
sponse elements (i.e. nucleotide sequences specifically
recognized by sex hormone receptors) on the promoter
regions of the target genes, thus regulating gene
expression by interacting with the transcription
machinery [7,8]. However, the observation of sex
hormone-elicited effects that are too rapid to be
mediated by activation of RNA and protein synthesis
has prompted the search for alternative signaling
mechanisms. Additional indications to new ways of sex
hormone signaling have been provided by the discovery
of receptor subfractions localized at the cell membrane
level [9,10], which are potentially responsible for the
non-nuclear effects of sex hormones. Non-genomic
steroid activity typically involves the rapid induction of
conventional second-messenger signal transduction
cascades, including increases in free intracellular calcium,
and activation of protein kinase A, protein kinase C, and
mitogen activating phosphokinase (MAPK) [11].
Second-messenger induction by non-genomic steroid
action is insensitive to inhibitors of transcription and
translation [11]. Commonly, these effects are observed
within seconds to minutes, considered too rapid to
involve changes in transcription and protein synthesis.
However, the physiologic role of the non-genomic
activation of the MAPK pathway by sex hormones has
not been fully determined. Moreover, sex hormones
may function through the sex hormone-binding globu-
lin (SHBG) receptor [11]. In both of these cases, the
biologic relevance of such observations is not completely
clear; therefore, this review focuses on the classical role
of sex hormones acting on sex hormone receptors in
female ovulation, especially through the studies of
knockout female mouse models.
Overview of the Ovary
An understanding of ovarian morphology and physiology
are necessary for a discussion of phenotypes that result
from a lack of androgen receptor (AR), estrogen receptor
(ER), and progesterone receptor (PR). Couse and Korach
have published an excellent review [12]. The ovary may
be conveniently divided into three broad functional
units: the follicles, corpora lutea, and interstitial/stromal
compartment. All three possess the capacity to synthe-
size hormonal factors, especially steroids, in response
to gonadotropins secreted from the anterior pituitary.
Ovarian function is often divided into two separate
phases. The follicular phase refers to the period of
follicle maturation and increased estrogen synthesis
that leads up to and terminates with ovulation. Ovulation
marks the beginning of the luteal phase in which the
developing corpora lutea secrete large amounts of
progesterone as well as estrogen to allow successful
implantation of blastocysts in the uterus. During the
follicular phase, the follicles may be categorized based
on size, responsiveness to gonadotropins, and
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steroidogenic capabilities as the primordial, primary,
secondary, tertiary or antral, atretic, and mature Graafian
follicle. In consonance with its gametogenic function,
the ovary fulfills a critical role as an endocrine organ,
serving as the principal source of sex steroids in the
female. Therefore, a normally functioning ovary is an
essential prerequisite to the function and maintenance
of the reproductive tract, mammary glands, and female
behavior. As indicated previously, the two-cell, two-
gonadotropin model shows that the two steroid-
producing components of the maturing follicle are the
thecal and granulosa cells, which predominantly produce
androgens and estrogens, respectively, although recent
data have challenged the “two-cell” model to incorporate
the description of a role for the oocyte in regulating gra-
nulosa cell steroidogenesis. Elegant in vitro experiments
involving the surgical removal of the oocyte from isolated
growing follicles have demonstrated the existence of an
oocyte-secreted factor that can inhibit granulosa cell
estradiol and progesterone synthesis [13,14].
Androgen Receptor
Androgens, primarily testosterone, are produced by
thecal cells in response to LH [1]. Androgens target
granulosa cells where, via the AR, they initiate three
possible scenarios depending on the developmental
status of the follicles [15]. AR, first cloned in 1988 [16,
17], is found in many tissues in both sexes but is most
abundant in male reproductive tissues and the female
ovary. The best-characterized function of AR is to
promote the growth and differentiation of the male
urogenital structures [18–22]. AR knockout male mice
show severe abnormality in prostate development and
penile growth and are infertile [18]. In contrast, studies
on the testicular feminized mouse (Tfm), which lacks
functional ARs, indicate that ARs are not essential for
fertility [23]. AR can be phosphorylated and reversible
phosphorylation appears to play a role in both ligand-
dependent and -independent activation [24]. Before
binding its ligand, AR is thought to be in an inactive
state in which it is bound to at least two Hsps (Hsp90
and Hsp70) and other cellular chaperones [25]. In this
state, it is unable to influence the transcription rate of
its target gene promoters. Once testosterone has entered
the cell, it is usually converted to dehydroxytestosterone
(DHT) by 5_-reductase or serves as a substrate for
synthesis of estrogen in ovarian granulosa cells. AR can
bind to both testosterone and DHT. In fact, DHT has a
higher affinity for AR than testosterone (approximately
2- to 10-fold). On binding with androgen or ligands, AR
undergoes a series of events including conformational
changes, dissociation from Hsp-protein complexes,
dimerization, phosphorylation, and nuclear translo-
cation. The activated AR can recognize palindromic
DNA sequences, called androgen response elements,
and form a complex with AR-associated proteins to
induce the expression of AR target genes. The binding
of hormones to androgen response elements causes
the recruitment of co-activators and basal transcrip-
tion machinery, leading to the up-regulation of target-
gene transcription [8]. During the early stages of fol-
liculogenesis, androgen promotes the FSH-mediated
differentiation of granulosa cells by amplifying cyclic
adenosine monophosphate-mediated post-receptor
signaling [1]. As follicular differentiation progresses,
this effect is decreased and androgen is mainly used as
a substrate for estrogen synthesis under increasing
stimulation of FSH and LH [15]. During late preovula-
tory development, AR declines and androgens are
metabolized as opposed to exerting direct effects on
folliculogenesis. The androgens act as substrates for
estrogen synthesis under the classical two-cell, two-
gonadotropin model [2,3]. Despite these apparent
actions of androgens in the ovary, the effects of andro-
gens in ovulation are still uncertain, mostly because of
the lack of an in vivo model to study the role of AR
deficiency in female ovulation.
ARs are present in the ovaries of primates, including
humans, and other mammals at almost all stages of the
reproductive cycle. Exogenous androgens influence
follicular development in vivo. Larger amounts of AR
protein in granulosa cells of small compared with larger
antral follicles have been observed in pigs, rats, and
primates, and this might facilitate FSH actions in early
antral follicles, a critical period of FSH influence on
follicular development, by positively regulating the FSH
receptor [26]. Androgen treatment induces expression
of insulin-like growth factor-I and insulin-like growth
factor-I receptors and enhances the growth of immature
follicles in the primate ovary [27,28]. However, excessive
AR may enhance the detrimental effects of androgens
on follicular development and, perhaps, decrease the
amount of androgen necessary for estrogen synthesis in
late-developing follicles in rats [12], although this is not
supported by pig data. ARs can inhibit follicular
development by increasing follicular atresia [29–31]. So
far, the understanding of the role of androgens and AR
in the female reproductive function including ovulation
and infertility is limited. Recently, two groups have
developed androgen receptor knockout (ARKO) mouse
models to clarify the issue [18,32]. Using a cre-lox
conditional knockout strategy to produce ARKO mice,
we may be able to evaluate the role of AR in ovulation
and female fertility [18,32–34].
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Defective Ovulation in ARKO Female Mice
Detailed data from a fertility study in ARKO female mice
have recently been published [34]. In brief, the litter size
and number of litters are significantly decreased in
ARKO female mice during 12 weeks of mating testing.
The causes of these decreases are many, but this review
will focus on the ovulation defects. The metestrus cycle
of ARKO female mice is significantly longer than that of
wild-type female mice. In addition, a few ARKO female
mice were infertile at 5–6 months of age, suggesting that
the reproductive lifespan of some but not all ARKO
female mice may be shortened compared with that of
wild-type female mice. This phenomenon is in agreement
with Tfm mice data, which show that the reproductive
lifespan of Tfm mice is reduced due to accelerated ag-
ing of the ovary [23]. To further dissect the ovulation
capacity, we performed a superovulation test with
exogenous gonadotropins in immature ARKO and wild-
type female mice at 25 days of age to determine the
oocyte production per female [34]. ARKO female mice
produced fewer oocytes compared with wild-type female
mice and heterozygous female mice. In addition, the
structure of the cumulus cell–oocyte complexes from
ARKO female mice was less condensed and less intact
than those from wild-type female mice. After 0.3%
hyaluronidase treatment, the dissociation of oocytes
from the surrounding cumulus cells occurred more
quickly in complexes from ARKO female mice. Either
one or the combination of both will contribute to the
reduced fertility of ARKO female mice.
Estrogen Receptor
Since the discovery of estrogens in the early 1920s [35],
their effects have intrigued reproductive biologists [36].
Transgenic gene knockout technology has been used to
investigate the intra-ovarian effects of estrogen. Mice
that lack either the P450arom gene [37,38] or one or both
of the known ERs (ER_ and ER`) have been produced
[39–42]. The main ovarian events studied for estrogen
involvement have been folliculogenesis, steroidogenesis,
ovulation, and corpus luteum formation [36]. The
estrogen signaling system consists of the hormone 17`-
estradiol and ER_ and ER` located within the nuclei of
target cells [43–46]. These two receptors have consider-
able sequence identity in the DNA-binding domains,
which permits both receptor types to interact with the
ER elements of various genes [35]. Sequence differences
between the two receptors occur primarily in the N- and C-
terminal regions [45,46]. As in other estrogen-responsive
organs, such as the uterus, estrogen down-regulates
granulosa cell expression of ER` protein [47]. Both ERs
are considered Class I members of the superfamily of
nuclear receptors, characterized as ligand-inducible
transcription factors [48–50]. ERs can also act as co-
regulators through binding to other transcription factors
already attached to the gene regulatory region [51,52],
and by ligand-independent mechanisms [53].
As ovarian follicles grow and differentiate, increasing
amounts of estrogen are produced [35], which up-
regulates the synthesis and release of the pituitary
gonadotropins FSH and LH, thereby promoting ovarian
follicular growth. Estrogen also increases follicular
expression of both FSH and LH receptors in rat granulosa
cells [54]. The ovary contains both ER subtypes, with a
predominance of ER` over ER_ in granulosa cells.
Despite extensive research into the production of
estradiol, the principal estrogen, by follicles and the
structure and function of the respective ERs, the specific
roles of estradiol and its receptors in the ovary have
remained unexpectedly elusive [55]. Britt and Findlay
have recently published an excellent review addressing
steroid receptor expression in the ovary [56]. In brief,
from the indifferent stage of gonadal development to
birth in rodents, ER_ is predominantly expressed within
the female gonad. ER_ has been detected in increasing
levels from 13.5 to 18.5 days post coitum (dpc) [57].
Other investigators have identified both _ and ` mRNA
expression at 14 dpc [58]. After birth, there is cell-
specific localization of ER concurrent with follicle
formation and growth. ER_ mRNA has been identified
at postnatal day (PND) 12 in thecal and interstitial cells,
while granulosa cells express ER` mRNA from PND 4–
6 [58]. As preantral and antral follicles develop, the
granulosa cells express ER` protein and there is a peak
in ER` mRNA expression by PND 26 [59]. Localization
of ER_ in granulosa cells remains controversial [56].
Adult ovaries possess similar expression profiles to
postnatal ovaries, with ER_ localized to thecal and
interstitial cells and the germinal epithelium. ER` is
localized to the granulosa cells of small, medium, and
large follicles and is regulated by gonadotropins [60].
The differentiating effects of estrogen are, therefore,
likely to be induced directly in the somatic cells of the
gonad. It remains possible that the influence of germ
cells (oocytes) on somatic-cell phenotype in the ovarian
follicle could be partly mediated by estrogens.
Defective Ovulation in ER Knockout Female
Mice
The advent of ER_ knockout (_ERKO), ER` knockout
(`ERKO), and compound ER_` knockout (_`ERKO)
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mice offers an opportunity to define the actions of
estrogen in folliculogenesis in a more exact way [12,39–
42,48,61]. The ovaries of neonatal and prepubertal
_ERKO female mice do not exhibit any gross differences
compared with those of wild-type littermates [48]. The
mature _ERKO ovary possesses a normal complement
of primordial follicles, indicating no defects in germ-cell
generation or migration to the gonad during fetal
development. However, at the commencement of sexual
maturity, it becomes apparent that _ERKO female mice
are acyclic and infertile and possess hyperemic ovaries
devoid of corpora lutea [49]. Folliculogenesis is arrested
at the antral stage with large secondary follicles becoming
cystic and hemorrhagic within 3 weeks of birth. These
cystic structures often accumulate in the ovary, making
the gonad appear grossly as a bundle of dark grapes, a
signature phenotype of _ERKO female mice [12].
A discussion of estradiol and ovarian function must
also include the hormonal actions of estrogen in the
hypothalamic-pituitary axis that are critical to folliculo-
genesis and ovulation [50]. Gonadotropin synthesis
and secretion from the anterior pituitary is at least
partially regulated by gonadal steroids acting via classic
feedback mechanisms in the hypothalamus and pituitary
[50]. Indeed, disruption of the ER_ gene results in the
loss of the negative-feedback loop of estradiol on LH
secretion, congruent with ER_ being the predominant
form of ER in the mouse pituitary. This hypersecretion
of LH from the anterior pituitary results in chronic
hyperstimulation of the ovary, illustrated by polycystic
and hemorrhagic follicles and elevated serum testos-
terone and estradiol levels in _ERKO female mice.
Anovulation in adult _ERKO female mice cannot be
rescued even after appropriate stimulation with exog-
enous gonadotropins [49], indicating that infertility
in _ERKO female mice is due, in large degree, to
alterations in the hormonal milieu and ovarian re-
sponsiveness [12]. _ERKO female mice have provided a
number of indications that intraovarian ER_ action is
not critical to ovarian function. Based on the reported
localization of ER` mRNA and protein to the granulosa
cells of growing follicles [12], as well as the maintenance
of a normal expression pattern for ER` in _ERKO
female mice [49], it is likely that ER` may be the pre-
dominant mediator of estrogen action in the follicle.
Interestingly, `ERKO female mice also possess no gross
aberrant phenotypes as neonates or during adulthood
[40]. However, just like the ARKO female mice, during
a continuous mating study of 8 weeks in which sexually
mature wild-type or `ERKO female mice were housed
with a known fertile wild-type male, a significant deficit
in fertility in `ERKO female mice became obvious. The
`ERKO female mice produced substantially fewer litters
as well as significantly fewer pups per litter compared
with their wild-type littermates. The nature of the
subfertility in `ERKO female mice described above
strongly suggests an ovarian phenotype. Gross analysis
of `ERKO female ovaries shows no distinct differences
in size or morphology compared with those of wild-type
female mice [12], although some `ERKO female mice
may have small ovaries [61]. Histologic analysis of
sexually mature `ERKO female ovaries illustrates the
presence of a relatively normal interstitial compartment
and follicles at various stages of the follicular cycle,
ranging from primordial and primary follicles to those
with a clearly defined antrum, all possessing the expected
thecal shell. Gonadotropin levels are normal in these
`ERKO female mice. The ovulatory capacity of the
`ERKO female mice is dramatically reduced compared
with that of wild-type female mice [40]. The cumulus
mass that surrounds ovulated follicles from `ERKO
female mice is consistently composed of fewer cells and
decreased integrity compared with ova from wild-type
female mice [12]. Histology of `ERKO female ovaries
shows the presence of numerous preovulatory but
unruptured follicles. Thus, follicular development is
greater in `ERKO than _ERKO mice [12]. _ERKO mice
have a block in folliculogenesis at the early antral stage
before the increase in granulosa cell proliferation [62],
whereas `ERKO female mice have antral follicles and
can ovulate but show some impairments [40].
Analysis of ovaries from adult _`ERKO female mice
shows a clearly distinct phenotype from that exhibited
by the individual ERKO models [41]. A variety of struc-
tures are present in adult _`ERKO ovaries, including
those appropriate to the normal ovary such as multiple
primordial and growing follicles [50]. Also present are
larger follicles that possess a thecal shell and basal
lamina that surrounds multiple layers of granulosa cells,
but almost always a degenerating oocyte. Cystic folli-
cles characteristic of those found in the _ERKO ovary,
although not as large or as hemorrhagic, are also present
in the _`ERKO ovary. However, the most striking feature
of the _`ERKO ovary is the presence of many structures
resembling the seminiferous tubules of the testis, which
predominate in large portions of the ovary [41]. These
structures consistently possess an intact basal lamina,
but lack the concentric layers of granulosa cells
characteristic of a maturing follicle, and possess either
a degenerating oocyte or no germ cell at all. The lumen
of the seminiferous tubule-like structures contains
apoptotic granulosa cells and cells strongly resembling
the Sertoli cells of the testis. The ovaries of prepubertal
_`ERKO females do not exhibit these features of sex-
reversal, but do exhibit multiple large follicles not
normally seen in a neonatal ovary. Couse and Korach
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suggest a redifferentiation of the ovarian follicle in
_`ERKO female mice rather than a developmental
phenomenon [50], indicated by the absence of semini-
ferous tubule-like structures and Sertoli cells in the
prepubertal _`ERKO, the consistent spherical shape
of the tubules suggesting that they originate from a
once-healthy follicle, and the age-related increases in
the area of transdifferentiation. The _`ERKO ovary
shows ectopic expression of two known biochemical
indices of Sertoli-cell differentiation, sulfated glyco-
protein-2 [63] and Sox9 [64]. Rapid increases in Sox9
expression occur following the appearance of Sry in
the somatic cells of the XY genital ridge and later in
Sertoli cells of the fetal testis [64]. Therefore, the Sox9
protein is believed to play a critical role in Sertoli-cell
differentiation and subsequent commitment to the male
pathway. Remarkably, the levels of Sox9 transcripts in
the adult _`ERKO ovary are similar to those found in
day-16 dpc mouse testis [50].
Progesterone Receptor
Progesterone plays a central role in the reproductive
events associated with pregnancy establishment and
maintenance [65,66]. The physiologic effects of proges-
terone are mediated by interaction with specific intra-
cellular PRs that are members of the nuclear receptor
superfamily of transcription factors [67–70]. PRs are
expressed as two protein isoforms, PR-A and PR-B,
produced from a single gene by transcription from two
distinct promoters and by translation initiation at two
alternative AUG signals. Analysis of the structural and
functional relationships of each isoform using in vitro
systems has shown that the PR-A and PR-B proteins
have different transcription activation properties when
bound to progesterone. The expression of both iso-
forms is conserved in rodents and humans and overlaps
spatiotemporally in female reproductive tissues. How-
ever, the ratios of the individual isoforms vary in repro-
ductive tissues as a consequence of developmental [71]
and hormonal status [72] and during carcinogenesis
[73]. PRs have a modular protein structure consisting of
distinct functional domains capable of binding steroidal
ligands, dimerization of liganded receptors, interaction
with hormone responsive DNA elements and interaction
with coregulator proteins required for bridging recep-
tors to the transcriptional apparatus [74]. Binding of
progestin agonists to receptors induces conformational
changes in receptor structure that promote interaction
of coactivator proteins with distinct activation domains
located within both the N- and C-terminal regions of the
receptors [65]. Such coactivators promote chromatin
remodeling and bridging with general transcription
factors, resulting in the formation of productive
transcription initiation complexes at the receptor
responsive promoters. In contrast, binding of receptor
antagonist compounds induces receptor conformational
changes that render activation domains non-permissive
to coactivator binding and instead promote interaction
with corepressor proteins that inhibit transcriptional
activity. Importantly, PRs can also be activated in the
absence of a steroidal ligand by phosphorylation
pathways that modulate their interactions with co-
regulator proteins [75]. The PR-A and PR-B isoforms
differ in that the PR-B protein contains an additional
sequence of amino acids at its N-terminus. This PR-B-
specific domain encodes a third transactivation function
(AF3) that is absent from PR-A [76]. Recent evidence
has demonstrated that the presence of AF3 allows
binding of a subset of coactivators to PR-B that are not
efficiently recruited by progestin-bound PR-A [77]. Thus,
when expressed individually in cultured cells, PR-A and
PR-B display different transactivation properties that
are specific to both cell type and target-gene promoter
context [78] and are associated with a differential
ability of PR-A and PR-B to recruit specific coregulator
proteins. Agonist-bound PR-B functions as a strong
activator of transcription of several PR-dependent
promoters and in a variety of cell types in which PR-A is
inactive. Furthermore, when both isoforms are co-
expressed in cultured cells, in cell and promoter con-
texts in which agonist-bound PR-A is inactive, PR-A can
repress the activity of PR-B. This repressor capacity also
extends to other steroid receptors including ER_ [79].
Finally, the PR-A and PR-B proteins respond differently
to PR-progesterone antagonists [80]. Although the
sequence of the LBDs of PR-A and PR-B are identical,
the ability of different ligands to induce different
conformational changes in PR, together with the
synergistic activity of the N- and C-terminal activation
domains, predicts that PR-A or PR-B selective tran-
scriptional regulation can be achieved by manipula-
ting ligand interactions with the C-terminal.
Defective Ovulation in PR Knockout Female
Mice
Evidence that ovary-derived progesterone may
participate in autocrine regulation of ovarian function
first emerged when it was demonstrated that LH, the
primary signal for rupture of preovulatory ovarian folli-
cles leading to ovulation, can stimulate transient expres-
sion of PR mRNA and protein in granulosa cells iso-
lated from preovulatory follicles [65] and that the
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antiprogestin RU486 can inhibit ovulation [81]. The
advent of PR-A knockout (PRAKO), PR-B knockout
(PRBKO), and PR knockout (PRKO) female mice may
offer an opportunity to define the actions of progesterone
in folliculogenesis in a more exact way [82–84]. Definitive
proof that PRs are essential mediators of ovulation has
been provided through analysis of the ovarian pheno-
type of PRKO female mice [82]. Despite exposure to
superovulatory levels of gonadotropins, PRKO female
mice fail to ovulate [82]. Analysis of the histology of
these PRKO female mice has revealed normal
development of intraovarian follicles to the tertiary
follicular stage [82]. The follicles contain a mature
oocyte that is fully functional when isolated and ferti-
lized in vitro. However, follicular rupture is effectively
eliminated. Despite the ovulatory block, preovulatory
granulosa cells within these follicles can differentiate
into a luteal phenotype and express the luteal marker
P450scc [85]. Thus, PR is required specifically for LH-
dependent follicular rupture leading to ovulation but
not for differentiation of granulosa cells to form a
corpus luteum (luteinization). Follicular rupture requires
induction of a prostaglandin-mediated inflammatory
response to LH as well as tissue degradation at the apex
of the preovulatory follicle, an event that is mediated by
matrix-digesting proteinases [66]. Recent investigations
to examine the molecular events associated with
ovulation that are mediated by PRs have shown that PRs
are induced specifically in the mural granulosa cells of
the mature tertiary follicle and are absent from the
cumulus granulosa cells that surround the oocyte [85].
Analysis of potential ovulation-mediator expression in
PRKO female mice has demonstrated that LH-induced
regulation of cyclooxygenase-2, an enzyme that cata-
lyzes prostaglandin production, is unaffected [85]. In
contrast, the expression of two metalloproteinases,
ADAMTS-1 (a desintegrin and metalloproteinase with
thrombospondin motifs) and cathepsin-L (a lysosomal
cystein protease) is inhibited in granulosa cells of ma-
ture follicles in PRKO female mice [85], suggesting
that ADAMTS-1 may be a critical mediator of the
progesterone-induced ovulatory event. In fact, ovulation
involves multiple genes and goes through a multistep
process [86]. Previous studies have indicated that both
PR-A and PR-B are induced in preovulatory follicles in
response to LH stimulation [87]. Stimulation of
immature PRAKO female mice with gonadotropins
indicates that superovulation is severely impaired in
these mice relative to their wild-type counterparts but,
unlike in PRKO female mice, is not completely absent.
In contrast, superovulation is unaffected in PRBKO
female mice expressing only the PR-A protein. Thus, PR-
A expression is both necessary and sufficient to mediate
the ovulatory response to progesterone. Histologic
analysis of the ovaries from PRAKO female mice shows
numerous mature anovulatory follicles that contain an
intact oocyte and are arrested at a similar stage to that
previously observed in PRKO female mice. However, in
contrast to PRKO female mice, progesterone’s spatio-
temporal regulation of ADAMTS-1 and cathepsin-L is
unaffected. Thus, despite its inability to mediate fol-
licular rupture, PR-B is functional in the ovary and
capable of regulating a subset of progesterone-
responsive target genes [66]. The observation that PR-
A and PR-B are not functionally redundant in the ovary
provides physiologic validation of previous studies in
tissue culture demonstrating that these transcriptional
factors have different functional activities. From a
mechanistic standpoint, the observation that PR-A alone
is sufficient to support normal ovulation indicates that
heterodimeric interactions between PR-A and PR-B
proteins are not required to regulate essential progestin-
responsive target genes associated with ovulation [66].
Conclusion
Over the past decade, significant progress has been
made in understanding the collective and selective
contribution of sex hormone receptors (AR, PR-A, PR-
B, ER_, and ER`) to the signaling pathway controlled
by sex hormones. The fertility outcome in all selective
sex hormone receptor knockout female mice is summa-
rized in Table 1. Further analysis of oocyte status after
superovulation in selective sex hormone receptor
knockout female mouse models is summarized in Table
2. Although genetic mouse models have revealed the
classical role of sex hormone–sex hormone receptor in
ovulation, the non-genomic pathway and isoform-
specific pathway are not yet fully understood. Using the
same strategy, these genetic mouse models will provide
Table 1. Fertility outcome of selective sex hormone









PRKO = progesterone receptor knockout; PRAKO = progesterone receptor-
A knockout; PRBKO = progesterone receptor-B knockout; _`ERKO =
estrogen receptor _`knockout; _ERKO = estrogen receptor _ knockout;
`ERKO = estrogen receptor `  knockout; ARKO = androgen receptor knockout.
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valuable tools to address the physiologic significance of
ligand-independent pathways of receptor activation as
well as the contribution of specific receptor subtypes to
the activities of tissue-selective receptor modulators.
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